Trial intelligence / Profile preview

Tetrandrine for silicosis in artificial quartz conglomerate workers

ChiCTR2000032722Phase 4Not yet recruiting

Sponsor
Shanghai Pulmonary Hospital
Start
Jun 2020
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of tetrandrine in silicosis, sponsored by Shanghai Pulmonary Hospital. Primary endpoint: Chest CT scan. Planned start Jun 2020; status: not yet recruiting.

02

Drugs

tetrandrine
03

Conditions

silicosis

Beyond the preview

Go deeper on ChiCTR2000032722.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000032722.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call